These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8074464)

  • 1. Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles.
    Runnebaum IB; Yee JK; Kieback DG; Sukumar S; Friedmann T
    Anticancer Res; 1994; 14(3A):1137-44. PubMed ID: 8074464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
    Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
    Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate.
    Chen YM; Chen PL; Arnaiz N; Goodrich D; Lee WH
    Oncogene; 1991 Oct; 6(10):1799-805. PubMed ID: 1923505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirally mediated wild-type p53 restores S-phase modulation without inducing WAF1 mRNA in breast carcinoma cells containing mutant p53.
    Runnebaum IB; Wang S; Kreienberg R
    J Cell Biochem; 1995 Dec; 59(4):537-44. PubMed ID: 8749722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
    Casey G; Lo-Hsueh M; Lopez ME; Vogelstein B; Stanbridge EJ
    Oncogene; 1991 Oct; 6(10):1791-7. PubMed ID: 1923504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
    Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
    Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
    Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
    Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells.
    Wang NP; To H; Lee WH; Lee EY
    Oncogene; 1993 Feb; 8(2):279-88. PubMed ID: 8426737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.
    Isaacs WB; Carter BS; Ewing CM
    Cancer Res; 1991 Sep; 51(17):4716-20. PubMed ID: 1873816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype.
    Frebourg T; Sadelain M; Ng YS; Kassel J; Friend SH
    Cancer Res; 1994 Feb; 54(4):878-81. PubMed ID: 8313374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth suppression of normal mammary epithelial cells by wild-type p53.
    Merlo GR; Venesio T; Taverna D; Marte BM; Callahan R; Hynes NE
    Oncogene; 1994 Feb; 9(2):443-53. PubMed ID: 8290256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H; Lai B; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53.
    Qazilbash MH; Xiao X; Seth P; Cowan KH; Walsh CE
    Gene Ther; 1997 Jul; 4(7):675-82. PubMed ID: 9282168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early ultraviolet B-induced G1 arrest and suppression of the malignant phenotype by wild-type p53 in human squamous cell carcinoma cells.
    Courtois SJ; Woodworth CD; Degreef H; Garmyn M
    Exp Cell Res; 1997 May; 233(1):135-44. PubMed ID: 9184083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
    Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M
    Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.
    Katayose D; Gudas J; Nguyen H; Srivastava S; Cowan KH; Seth P
    Clin Cancer Res; 1995 Aug; 1(8):889-97. PubMed ID: 9816059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
    Montano X
    Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein.
    Vinyals A; Peinado MA; Gonzalez-Garrigues M; Monzó M; Bonfil RD; Fabra A
    Gene Ther; 1999 Jan; 6(1):22-33. PubMed ID: 10341872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.